doi: 10.5114/ada.2018.75748.
Epub 2018 Jul 19.
Acute urticaria: an extremely rare adverse effect of levonorgestrel-releasing intrauterine system as a possible manifestation of progestogen hypersensitivity syndrome
Affiliations
- PMID: 30429715
- PMCID: PMC6232535
- DOI: 10.5114/ada.2018.75748
Item in Clipboard
Acute urticaria: an extremely rare adverse effect of levonorgestrel-releasing intrauterine system as a possible manifestation of progestogen hypersensitivity syndrome
Postepy Dermatol Alergol.
2018 Oct.
No abstract available
Conflict of interest statement
The authors declare no conflict of interest
Similar articles
-
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006. Drug Saf. 1996. PMID: 8968696 Review.
-
The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.Climacteric. 2004 Dec;7(4):404-11. doi: 10.1080/13697130400012270. Climacteric. 2004. PMID: 15799612 Clinical Trial.
-
Levonorgestrel-releasing intrauterine system--the discontinuing story.Gynecol Endocrinol. 2009 Oct;25(10):668-73. doi: 10.1080/09513590903159656. Gynecol Endocrinol. 2009. PMID: 19657812 Review.
-
Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.Obstet Gynecol. 2012 Mar;119(3):519-26. doi: 10.1097/AOG.0b013e31824264c3. Obstet Gynecol. 2012. PMID: 22314873 Clinical Trial.
-
Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.Reprod Sci. 2016 Jul;23(7):877-84. doi: 10.1177/1933719115623648. Epub 2016 Jan 4. Reprod Sci. 2016. PMID: 26733500
Cited by
-
Chronic Urticaria Suspected to be Caused by a 13.5 mg Levonorgestrel Intrauterine Device (Skyla®).Cureus. 2023 Jul 22;15(7):e42287. doi: 10.7759/cureus.42287. eCollection 2023 Jul. Cureus. 2023. PMID: 37609103 Free PMC article.
References
-
- Mansour D. The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. Contraception. 2012;85:224–34. - PubMed
-
- Hardeman J, Weiss BD. Intrauterine devices: an update. Am Fam Physician. 2014;89:445–50. - PubMed
-
- Mirena – product information. Available at: http://www.bayerresources.com.au/resources/uploads/PI/file9399.pdf.
-
- Cox M, Tripp J, Blacksell S. Clinical performance of the levonogestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plann Reprod Health Care. 2002;28:73–7. - PubMed
LinkOut - more resources
Full Text Sources
